🇺🇸 FDA
Patent

US 11185562

Compositions and methods for inhibition of pathogenic bacterial growth

granted A61KA61K35/37A61K35/74

Quick answer

US patent 11185562 (Compositions and methods for inhibition of pathogenic bacterial growth) held by Seres Therapeutics, Inc. expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Seres Therapeutics, Inc.
Grant date
Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K35/37, A61K35/74, A61K35/741, A61K35/742